
ANI Pharmaceuticals shares rise on positive eye implant trial amid insider stock sales
ANI Pharmaceuticals saw its stock rise following successful Phase 4 clinical trial results for an implant improving vision in a chronic eye condition. Despite the positive news, insiders including the Senior VP and CFO sold shares recently after the ...


